Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)
|
September 27, 2001
Gene-directed enzyme prodrug therapy (GDEPT)--recognizing the present limitations of gene therapy for the treatment of cancer
R J Knox
Biochemical Pharmacology
|
August 18, 1992
Metabolism of NAD(P)H by blood components. Relevance to bioreductively activated prodrugs in a targeted enzyme therapy system
F Friedlos, R J Knox
Stem Cells (Dayton, Ohio)
|
September 1, 1995
Prodrugs in cancer chemotherapy
T A Connors, R J Knox
Brain Research
|
July 7, 1987
Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones
R J Knox, A H Dickenson
Electrophoresis
|
March 22, 2001
Particle electrophoresis for quality assurance and process control
G V Seaman, R J Knox
Neuroscience Letters
|
March 31, 1987
Antagonism of mu-opioid receptor-mediated inhibitions of nociceptive neurones by U50488H and dynorphin A1-13 in the rat dorsal horn
A H Dickenson, R J Knox
Biochemical and Biophysical Research Communications
|
November 14, 1986
CB 1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells
J J Roberts, F Friedlos, R J Knox
Cancer Metastasis Reviews
|
June 1, 1993
The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT)
R J Knox, F Friedlos, M P Boland
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 1995
The chemotherapy of colon cancer
T A Connors, R Duncan, R J Knox
Mini Reviews in Medicinal Chemistry
|
October 9, 2002
Aerobic nitroreduction by flavoproteins: enzyme structure, mechanisms and role in cancer chemotherapy
J V Skelly, R J Knox, T C Jenkins
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
Current Opinion in Investigational Drugs (London, England : 2000)
|
September 27, 2001
Gene-directed enzyme prodrug therapy (GDEPT)--recognizing the present limitations of gene therapy for the treatment of cancer
R J Knox
Biochemical Pharmacology
|
August 18, 1992
Metabolism of NAD(P)H by blood components. Relevance to bioreductively activated prodrugs in a targeted enzyme therapy system
F Friedlos, R J Knox
Stem Cells (Dayton, Ohio)
|
September 1, 1995
Prodrugs in cancer chemotherapy
T A Connors, R J Knox
Brain Research
|
July 7, 1987
Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones
R J Knox, A H Dickenson
Electrophoresis
|
March 22, 2001
Particle electrophoresis for quality assurance and process control
G V Seaman, R J Knox
Neuroscience Letters
|
March 31, 1987
Antagonism of mu-opioid receptor-mediated inhibitions of nociceptive neurones by U50488H and dynorphin A1-13 in the rat dorsal horn
A H Dickenson, R J Knox
Biochemical and Biophysical Research Communications
|
November 14, 1986
CB 1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells
J J Roberts, F Friedlos, R J Knox
Cancer Metastasis Reviews
|
June 1, 1993
The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT)
R J Knox, F Friedlos, M P Boland
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 1995
The chemotherapy of colon cancer
T A Connors, R Duncan, R J Knox
Mini Reviews in Medicinal Chemistry
|
October 9, 2002
Aerobic nitroreduction by flavoproteins: enzyme structure, mechanisms and role in cancer chemotherapy
J V Skelly, R J Knox, T C Jenkins
Page
of 8